Genetic variants in the ADAMTS13 and SUPT3H genes are associated with ADAMTS13 activity

被引:23
|
作者
de Vries, Paul S. [1 ]
Boender, Johan [2 ]
Sonneveld, Michelle A. H. [2 ,3 ]
Rivadeneira, Fernando [1 ,4 ]
Ikram, M. Arfan [1 ,3 ,5 ]
Rottensteiner, Hanspeter [6 ]
Hofman, Albert [1 ]
Uitterlinden, Andre G. [1 ,4 ]
Leebeek, Frank W. G. [2 ]
Franco, Oscar H. [1 ]
Dehghan, Abbas [1 ]
de Maat, Moniek P. M. [2 ]
机构
[1] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands
[2] Erasmus MC, Dept Hematol, Rotterdam, Netherlands
[3] Erasmus MC, Dept Neurol, Rotterdam, Netherlands
[4] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands
[5] Erasmus MC, Dept Radiol, Rotterdam, Netherlands
[6] Baxter Innovat GmbH, Vienna, Austria
关键词
VON-WILLEBRAND-FACTOR; THROMBOTIC THROMBOCYTOPENIC PURPURA; FACTOR-CLEAVING PROTEASE; ABO BLOOD-GROUP; SACCHAROMYCES-CEREVISIAE; MYOCARDIAL-INFARCTION; MISSENSE MUTATION; LOW-FREQUENCY; TRANSCRIPTION; GENOME;
D O I
10.1182/blood-2015-02-629865
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A disintegrin and metalloproteinase with thrombospondin motifs 13(ADAMTS13) cleaves von Willebrand factor, reducing its prothrombotic activity. The genetic determinants of ADAMTS13 activity remain unclear. We performed a genome-wide association study of ADAMTS13 activity in the Rotterdam Study, a population-based cohort study. We used imputed genotypes of common variants in a discovery sample of 3443 individuals and replication sample of 2025 individuals. We examined rare exonic variant associations in ADAMTS13 in 1609 individuals using an exome array. rs41314453 in ADAMTS13 was associated with ADAMTS13 activity in both our discovery (beta, -20.2%; P=1.3 x 10(-33)) and replication sample (P = 3.3 x 10(-34)), and explained 3.6% to 6.5% of the variance. In the combined analysis of our discovery and replication samples, there were 2 further independent associations at the ADAMTS13 locus: rs3118667 (beta, 3.0; P = 9.6 x 10(-21)) and rs139911703 (beta, -11.6; P=3.6 x 10(-8)). In addition, rs10456544 in SUPT3H was associated with a 4.2 increase in ADAMTS13 activity (P = 1.13.6 x 10(-8)). Finally, we found 3 independent associations with rare coding variants in ADAMTS13: rs148312697 (beta, -32.2%; P = 3.7 x 10(-6)), rs142572218 (beta, -46.0%; P = 3.9 x 10(-5)), and rs36222275 (beta, -13.9%; P = 2.9 x 10(-3)). In conclusion, we identified rs41314453 as the main genetic determinant of ADAMTS13 activity, and we present preliminary findings for further associations at the ADAMTS13 and SUPT3H loci.
引用
收藏
页码:3949 / 3955
页数:7
相关论文
共 50 条
  • [1] Genetic variants in ADAMTS13 as well as smoking are major determinants of plasma ADAMTS13 levels
    Ma, Qianyi
    Jacobi, Paula M.
    Emmer, Brian T.
    Kretz, Colin A.
    Ozel, Ayse Bilge
    McGee, Beth
    Kimchi-Sarfaty, Chava
    Ginsburg, David
    Li, Jun Z.
    Desch, Karl C.
    BLOOD ADVANCES, 2017, 1 (15) : 1037 - 1046
  • [2] Variants in ADAMTS13 and Smoking Contribute to Plasma ADAMTS13 Level Variation
    Desch, Karl C.
    Ma, Qianyi
    Ozel, Ayse Bilge
    McGee, Beth M.
    Siemieniak, David R.
    Li, Jun Z.
    Ginsburg, David
    BLOOD, 2014, 124 (21)
  • [3] The VWF/ADAMTS13 axis in the antiphospholipid syndrome: ADAMTS13 antibodies and ADAMTS13 dysfunction
    Austin, S. K.
    Starke, R. D.
    Lawrie, A. S.
    Cohen, H.
    Machin, S. J.
    Mackie, I. J.
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 141 (04) : 536 - 544
  • [4] ADAMTS13 in nephrology [ADAMTS13 in der Nephrologie]
    Bockmeyer C.L.
    Modde F.
    Becker J.U.
    Der Nephrologe, 2013, 8 (1): : 69 - 70
  • [5] ADAMTS13 INHIBITOR ASSESSMENT WITH THE HEMOSIL ACUSTAR ADAMTS13 ACTIVITY ASSAY
    Valsecchi, C.
    Mirabet, M.
    Mancini, I.
    Schiavone, L.
    Mane-Padros, D.
    Peyvandi, F.
    HAEMATOLOGICA, 2019, 104 : 23 - 24
  • [6] ADAMTS13 missense variants associated with defective activity and secretion of ADAMTS13 in a patient with non-cirrhotic portal hypertension
    Goel A.
    Raghupathy V.
    Amirtharaj G.J.
    Chapla A.
    Venkatraman A.
    Ramakrishna B.
    Ramachandran A.
    Thomas N.
    Balasubramanian K.A.
    Mackie I.
    Elias E.
    Eapen C.E.
    Indian Journal of Gastroenterology, 2017, 36 (5) : 380 - 389
  • [7] ADAMTS13 activity and genetic mutations in Japan
    Miyata, T.
    Kokame, K.
    Matsumoto, M.
    Fujimura, Y.
    HAMOSTASEOLOGIE, 2013, 33 (02): : 131 - 137
  • [8] Low ADAMTS13 antigen and activity and the presence of ADAMTS13 autoantibody suggest ADAMTS13 may play a role in venous thromboembolism
    Fryer, H. J. L.
    Hoecke, C. J.
    Wu, J. R.
    Guinto, E.
    Greenfield, R. S.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 426 - 426
  • [9] ADAMTS13 activity and inhibitor
    Doldan-Silvero, Adriana
    Acevedo-Gadea, Carlos
    Habib, Clandine
    Freeman, Jonathan
    Johari, Vandita
    AMERICAN JOURNAL OF HEMATOLOGY, 2008, 83 (10) : 811 - 813
  • [10] ADAMTS13 activity in cryoprecipitate
    Scott, E. A.
    Puca, K. E.
    Pietz, B. C.
    Friedman, K. D.
    TRANSFUSION, 2006, 46 (09) : 12A - 12A